SCHEMBL4584684

SCHEMBL4584684

O=C(Nc1ccccc1OC(F)(F)F)N(S)C1CCN(c2ncnc3cc(Cl)ccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
PDE10A Q9Y233 2/20 0.44
PDE3B Q13370 1/20 0.44
PDE3A Q14432 1/20 0.44
BTK Q06187 5/20 0.41
MALT1 Q9UDY8 2/20 0.41
PDGFRB P09619 3/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
KRAS P01116 1/20 0.39
CNR1 P21554 1/20 0.39
UBE2M P61081 1/20 0.39
DCUN1D1 Q96GG9 1/20 0.39
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
MAPK7 Q13164 1/20 0.39
RBP4 P02753 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4584198 0.87 KDM4E (0.55) PDGFRBKDM4EMAPTMAPK1
SCHEMBL4583105 0.84 CYP1A2 (0.48) CYP1A2CYP2D6MALT1PDGFRBMAPT
SCHEMBL4582331 0.83 CYP1A2 (0.50) CYP1A2CYP2D6MALT1PDGFRB
SCHEMBL4584212 0.83 CYP1A2 (0.53) CYP1A2CYP2D6MALT1PDGFRB
SCHEMBL4584679 0.83 CYP1A2 (0.50) CYP1A2CYP2D6PDE10APDE3BPDE3A
SCHEMBL4582530 0.82 KDM4E (0.47) PDGFRBKDM4EMAPTMAPK1UBE2M
SCHEMBL4581748 0.80 UBE2M (0.44) MALT1KDM4EUBE2MDCUN1D1
SCHEMBL4583134 0.79 PDGFRB (0.51) CYP1A2CYP2D6BTKMALT1PDGFRB
SCHEMBL4581558 0.78 PDGFRB (0.53) CYP1A2CYP2D6MALT1PDGFRB
SCHEMBL4583544 0.76 JAK2 (0.53) CYP1A2CYP2D6PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1903037-A1 1-(hetero)aryl-3-[heteroaryl-piperidin-4yl]-thiourea derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-03-26 EP claimed
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO claimed
EP-1903037-A1 1-(hetero)aryl-3-[heteroaryl-piperidin-4yl]-thiourea derivatives as modulators of EP2 receptors Bayer Schering Pharma Aktiengesellschaft (DE) 2008-03-26 EP disclosed
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed